Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medical Ventures tests dual-purpose balloon catheter in US CAD (coronary artery disease) trial

This article was originally published in Clinica

Executive Summary

Medical Ventures has stepped closer to taking to the lucrative coronary artery disease market its artery-measuring angioplasty balloon catheter, Metricath Gemini. It has begun an FDA-approved, multicentre trial of the dual-purpose device in patients undergoing coronary artery interventions. Data from the 155-patient study will be used to support a US marketing application for the product, which was cleared for use in peripheral arteries earlier this year. The Metricath Gemini catheter allows physicians to measure arterial size and assess stent deployment, as well as dilate a vessel or post-dilate an under-deployed stent using a single cost-effective catheter, said the Richmond, British Columbia firm.

Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT058206

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel